Ann Arbor's NanoBio brings in $12 million in venture capital

Concentrate, 2/26/2009

Despite the start-up's name, Ann Arbor's NanoBio isn't so small anymore with $12 million in new financing.

Excerpt:

NanoBio is attracting some big investment these days. The Ann Arbor-based firm just secured $12 million in new financing to help develop the company, bringing the total amount invested to $80 million.

The 3-year-old firm, University of Michigan spin-off, employs about 20 people and a handful of interns. It has hired several ex-Pfizer people after the pharmaceutical giant closed the doors to its Ann Arbor campus in 2007.

Read the rest of the story here.

Biotechnology , Healthcare , Higher Education , Investment , University Of Michigan - Dearborn

Ann Arbor